BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 25, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 30, 2009
View Archived Issues
Novel Rho kinase inhibitors in early development at Abbott
Read More
Merck KGaA claims sodium-glucose transporter inhibitors as antidiabetics
Read More
Johns Hopkins University describes novel protease inhibitors for treating HCV infection
Read More
HDAC1 inhibitors presented by Novartis for the treatment of cancer
Read More
Novel Plk-1 inhibitors identified by 4SC for the treatment of cancer
Read More
Abbott claims novel GlyT-1 inhibitors as anxiolytics
Read More
UAB, Southern Research and Jubilant Organosys enter joint venture
Read More
Cytokinetics discloses preclinical data on novel smooth muscle myosin inhibitors
Read More
Antimalaria vaccine elicits functional antibodies in phase I trial in malaria-naive subjects
Read More
ICOVIR-17 adenovirus displays enhanced intratumoral distribution and activity in vivo
Read More
GW-876008 improves stress-induced rectal hypersensitivity in patients with IBS
Read More
Preclinical characterization of RP-1040 disclosed at 2009 AACR-NCI-EORTC meeting
Read More
Novartis ends asthma and allergy research agreement with Idera Pharmaceuticals
Read More
Multaq approved in E.U. for treatment of atrial fibrillation
Read More
ATIR enters advanced clinical testing for graft-versus-host disease
Read More
Studies clarify genetic predisposition for Chlamydia trachomatis infections / News in Context
Read More
Complete response letter issued for extended indication of telavancin in the U.S.
Read More
European Commission approves Micardis for cardiovascular protection indication
Read More
EMEA validates ChemGenex's MAA for omacetaxine mepesuccinate
Read More
SciClone completes patient enrollment for SCV-07 phase II trial in oral mucositis
Read More
Roswell Park physician receives grant to investigate HDAC inhibitors in RCC
Read More
Photocure's NDA for Hexvix to be reviewed by FDA in December 2009
Read More
Approval of Pharmaxis' Aridol recommended by FDA advisory committee
Read More
MDRNA and Vancouver Prostate Center to extend collaboration on bladder cancer project
Read More
Encouraging phase II data on K-201 in atopic eczema announced by Moberg Derma
Read More
GlaxoSmithKline withdraws U.S. supplemental NDA for Avodart
Read More
GlaxoSmithKline discloses promising clinical data on H1N1 vaccine Pandemrix
Read More
